PropertyValue
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/ns/prov#value
  • Second, the FDA will not accept or approve any generic forms of the original OxyContin ER. REMOXY, an investigational drug, is a unique long acting oral formulation of oxycodone intended to treat moderate-to-severe pain when a continuous, around the clock opioid analgesic is needed for an extended period of time.
http://www.w3.org/ns/prov#wasQuotedFrom
  • prnewswire.com